{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:51:20Z","timestamp":1792450280279,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"publisher","award":["ANR-18-IBHU-0002"],"award-info":[{"award-number":["ANR-18-IBHU-0002"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejca.2026.116227","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T16:45:18Z","timestamp":1767977118000},"page":"116227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Lung-only metastatic pancreatic cancer: Differences in patients \u2018characteristics, molecular profile and survival"],"prefix":"10.1016","volume":"235","author":[{"given":"Alice","family":"Boil\u00e8ve","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3774-218X","authenticated-orcid":false,"given":"L\u00e9a","family":"Mercier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1061-321X","authenticated-orcid":false,"given":"Baptiste","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3804-3554","authenticated-orcid":false,"given":"Anthony","family":"Tarabay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Blanchet-Deverly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2869-7551","authenticated-orcid":false,"given":"Antoine","family":"Hollebecque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7568-6196","authenticated-orcid":false,"given":"Cristina","family":"Smolenschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7787-6911","authenticated-orcid":false,"given":"Marine","family":"Val\u00e9ry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2435-4757","authenticated-orcid":false,"given":"Matthieu","family":"Delaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Pudlarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Fuerea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7817-4663","authenticated-orcid":false,"given":"Val\u00e9rie","family":"Boige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9rome","family":"Durand-Labrunie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximiliano","family":"Gelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5917-3913","authenticated-orcid":false,"given":"Paul","family":"Beunon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4643-4492","authenticated-orcid":false,"given":"R\u00e9my","family":"Barbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9990-1201","authenticated-orcid":false,"given":"Aur\u00e9lien","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8649-7449","authenticated-orcid":false,"given":"Michel","family":"Ducreux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2026.116227_bib1","unstructured":"Cancer Tomorrow [Internet]. [cited 2025 Jul 31]. Available from: \u3008https:\/\/gco.iarc.who.int\/tomorrow\/\u3009."},{"issue":"4_","key":"10.1016\/j.ejca.2026.116227_bib2","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1200\/JCO.2025.43.4_suppl.786","article-title":"Updated trends in incidence and mortality of pancreatic cancer. an analysis of the surveillance, epidemiology, and end results (SEER) database","volume":"43","author":"Ntukidem","year":"2025","journal-title":"J Clin Oncol"},{"issue":"10242","key":"10.1016\/j.ejca.2026.116227_bib3","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","article-title":"Pancreatic cancer","volume":"395","author":"Mizrahi","year":"2020","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ejca.2026.116227_bib4","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1001\/jamasurg.2019.3337","article-title":"Patterns of recurrence after resection of pancreatic ductal adenocarcinoma: a secondary analysis of the ESPAC-4 randomized adjuvant chemotherapy trial","volume":"154","author":"Jones","year":"2019","journal-title":"JAMA Surg"},{"issue":"25","key":"10.1016\/j.ejca.2026.116227_bib5","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1056\/NEJMoa1809775","article-title":"FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer","volume":"379","author":"Conroy","year":"2018","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ejca.2026.116227_bib6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.5858\/133.3.413","article-title":"The pathology and genetics of metastatic pancreatic cancer","volume":"133","author":"Yachida","year":"2009","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"10.1016\/j.ejca.2026.116227_bib7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00006676-199511000-00005","article-title":"Hematogenous metastases of pancreatic ductal carcinoma","volume":"11","author":"Kamisawa","year":"1995","journal-title":"Pancreas"},{"issue":"1","key":"10.1016\/j.ejca.2026.116227_bib8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jso.23943","article-title":"The indolent nature of pulmonary metastases from ductal adenocarcinoma of the pancreas","volume":"112","author":"Downs-Canner","year":"2015","journal-title":"J Surg Oncol"},{"issue":"10 Pt A","key":"10.1016\/j.ejca.2026.116227_bib9","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.ejso.2020.06.013","article-title":"Metastases or primary recurrence to the lung is related to improved survival of pancreatic cancer as compared to other sites of dissemination. Results of a systematic review with meta-analysis","volume":"46","author":"Guerra","year":"2020","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2026.116227_bib10","article-title":"Prognosis and tumor biology of pancreatic cancer patients with isolated lung metastases: translational results from the German multicenter AIO-YMO-PAK-0515 study","volume":"7","author":"Kruger","year":"2022","journal-title":"ESMO Open [Internet]"},{"issue":"3","key":"10.1016\/j.ejca.2026.116227_bib11","first-page":"E48","article-title":"Pulmonary metastases in pancreatic cancer, is there a survival influence?","volume":"6","author":"Deeb","year":"2015","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.ejca.2026.116227_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.115125","article-title":"Defying the odds: outstanding survival in lung-only pancreatic cancer treated by Trifluridine-Tipiracil","volume":"214","author":"Sarti","year":"2025","journal-title":"Eur J Cancer"},{"issue":"34","key":"10.1016\/j.ejca.2026.116227_bib13","doi-asserted-by":"crossref","first-page":"36903","DOI":"10.18632\/oncotarget.5054","article-title":"Resected pancreatic ductal adenocarcinomas with recurrence limited in lung have a significantly better prognosis than those with other recurrence patterns","volume":"6","author":"Wangjam","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejca.2026.116227_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41588-025-02345-5","article-title":"Cellular states associated with metastatic organotropism and survival in patients with pancreatic ductal adenocarcinoma","author":"Chalabi Hajkarim","year":"2025","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.ejca.2026.116227_bib15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nri3789","article-title":"Immune cell promotion of metastasis","volume":"15","author":"Kitamura","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ejca.2026.116227_bib16","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/bs.pmbts.2016.09.008","article-title":"Molecular pathogenesis of pancreatic cancer","volume":"144","author":"Grant","year":"2016","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1016\/j.ejca.2026.116227_bib17","doi-asserted-by":"crossref","first-page":"6744","DOI":"10.1038\/ncomms7744","article-title":"Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets","volume":"6","author":"Witkiewicz","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.ejca.2026.116227_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.113497","article-title":"Precision medicine for KRAS wild-type pancreatic adenocarcinomas","volume":"197","author":"Ben-Ammar","year":"2024","journal-title":"Eur J Cancer"},{"issue":"12","key":"10.1016\/j.ejca.2026.116227_bib19","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1158\/1078-0432.CCR-21-3581","article-title":"Molecular characterization of KRAS wild-type tumors in patients with pancreatic adenocarcinoma","volume":"28","author":"Philip","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2026.116227_bib20","first-page":"22","article-title":"Oncogenic drivers and therapeutic vulnerabilities in KRAS wild-type pancreatic cancer","author":"Singh","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"19","key":"10.1016\/j.ejca.2026.116227_bib21","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.ejca.2026.116227_bib22","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Hoff","year":"2013","journal-title":"N Engl J Med"},{"issue":"10409","key":"10.1016\/j.ejca.2026.116227_bib23","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/S0140-6736(23)01366-1","article-title":"NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial","volume":"402","author":"Wainberg","year":"2023","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.ejca.2026.116227_bib24","first-page":"00824","article-title":"Pancreatic cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up\u2020","volume":"S0923-7534","author":"Conroy","year":"2023","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2026.116227_bib25","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.diii.2020.11.015","article-title":"CT features of lung metastases from pancreatic adenocarcinoma: correlation with histopathologic findings","volume":"102","author":"Aissaoui","year":"2021","journal-title":"Diagn Inter Imaging"},{"issue":"4","key":"10.1016\/j.ejca.2026.116227_bib26","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.pan.2016.03.016","article-title":"Isolated pulmonary metastases define a favorable subgroup in metastatic pancreatic cancer","volume":"16","author":"Kruger","year":"2016","journal-title":"Pancreatology"},{"key":"10.1016\/j.ejca.2026.116227_bib27","article-title":"Is survival influenced by metastatic site in synchronous metastatic pancreatic adenocarcinoma (PDAC)? A prospective real-world BACAP study","volume":"8","author":"Alouani","year":"2025","journal-title":"ESMO Gastrointest Oncol"},{"issue":"7","key":"10.1016\/j.ejca.2026.116227_bib28","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.3390\/cancers12071754","article-title":"Circulating cell-free dna-based liquid biopsy markers for the non-invasive prognosis and monitoring of metastatic pancreatic cancer","volume":"12","author":"Toledano-Fonseca","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"8066","key":"10.1016\/j.ejca.2026.116227_bib29","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41586-025-08927-x","article-title":"Spatial mapping of transcriptomic plasticity in metastatic pancreatic cancer","volume":"642","author":"Pei","year":"2025","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.ejca.2026.116227_bib30","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1038\/s43018-025-01047-5","article-title":"SMAD4 induces opposite effects on metastatic growth from pancreatic tumors depending on the organ of residence","volume":"6","author":"Tsanov","year":"2025","journal-title":"Nat Cancer"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926000079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926000079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T04:09:08Z","timestamp":1773979748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804926000079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":30,"alternative-id":["S0959804926000079"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116227","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lung-only metastatic pancreatic cancer: Differences in patients \u2018characteristics, molecular profile and survival","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116227","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116227"}}